Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 3.89 Delayed Data As of Dec 06 |  +0.09 / +2.39%Today’s Change | 2.33 Today|||52-Week Range 8.70 | +41.45% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | -6.7M | -6.1M | -7.5M | -7.0M | |
| Depreciation | 5.0K | 10.0K | 40.0K | 41.0K | ||
| Total Other Cash Flow | 1.5M | -1.2M | 421.0K | 563.0K | ||
| Funds From Operations | -5.3M | -7.3M | -7.0M | -6.4M | ||
| Funds From/For Other Operating Expenses | -128.0K | -399.0K | -101.0K | -1.4M | ||
| Net Cash Flow - Operating Activities | -5.1M | -6.9M | -6.9M | -5.0M | ||
| Investing | Increase In Investments | -58.6M | -20.5M | -21.3M | -27.9M | |
| Decrease In Investments | 0.00 | -- | 42.4M | 28.2M | ||
| Capital Expenditures | -13.0K | -151.0K | 0.00 | 0.00 | ||
| Other Investing - Uses | 0.00 | -499.0K | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -58.6M | -21.1M | 21.1M | 263.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -58.0K | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | -1.1M | 9.0K | 3.0K | 212.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -1.1M | 9.0K | 3.0K | 154.0K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -64.8M | -28.0M | 14.2M | -4.6M | ||
